Global /India /Healthcare /Drug Manufacturers - General /REMUS
chevron_leftBack
Remus Pharmaceuticals Ltd. logo

Remus Pharmaceuticals Ltd.

REMUS
NSE: REMUS Delayed
685.30INR -2.1%
7.26 USD
As of 20 June 2026, Remus Pharmaceuticals Ltd. has a market cap of $86.44M USD, ranking #26594 globally and #1652 in India. It ranks #2385 in the Healthcare sector, and #859 in the Drug Manufacturers - General industry.
Global Rank
26594
Country Rank
1652
Sector Rank
2385
Industry Rank
859
Key Stats
Market Cap
$86.44MUSD
8.16B INR
Enterprise Value
$89.17MUSD
8.42B INR
Revenue (TTM)
$79.24MUSD
7.48B INR
EBITDA (TTM)
$5.38MUSD
507.5M INR
Net Income (TTM)
$3.55MUSD
335.1M INR
EBITDA Margin
6.8%
Profit Margin
4.5%
PE Ratio
25.6
PS Ratio
1.1
PB Ratio
2.4
EV/EBITDA
16.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Arpit Shah open_in_new
Employees
68
Founded
2015
Website
remuspharma.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2.1% 9.5% 14% 7.4% 6.7% -31%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
REMUS
Remus Pharmaceuticals Ltd
ISIN: INE0O5T01011
Shares Out.:
11.784M1 Shares Float: 9.774M2
TV:
SA:
YF:
GF:
BA:
MS:
685.30 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Remus Pharmaceuticals Ltd.

Remus Pharmaceuticals Limited engages in the marketing, trading, and distribution of pharmaceuticals products and allied products in India and internationally. It is involved in trading of active pharmaceutical ingredient, as well as provides technical and consultancy services to various distributors and contract manufacturing services. The company offers tablet, hard and soft gelatine capsules, liquid and lyophilized injections, as well as pre-filled syringe, infusions, inhalers, nebulizers, nasal sprays and solutions, eye drops, creams, gels, ointments, suspensions, oral solutions and suspensions, sachets, and ophthalmic and other dosage forms. It also exports its products. Remus Pharmaceuticals Limited was incorporated in 2015 and is based in Ahmedabad, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$45.22B
4.27T INR
52K%
39.1
DIVISLAB
$18.38B
1.73T INR
21K%
70.0
$15.17B
1.43T INR
17K%
63.0
$11.73B
1.11T INR
13K%
19.6
MANKIND
$9.87B
931.67B INR
11K%
52.2
ZYDUSLIFE
$9.71B
916.53B INR
11K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
881K%
38.1
JNJ
$547.28B
633K%
26.4
ABBV
$360.63B
417K%
97.4
$318.3B
256.25B CHF
368K%
19.9
AZN
$284.64B
215.59B GBP
329K%
27.6
MRK
$274.03B
317K%
15.1
chevron_leftBack